BioMed Research International

Prognostic Assessment and Management of Liver Cirrhosis


Status
Published

Lead Editor

1General Hospital of Shenyang Military Area, Shenyang, China

2Western Sussex NHS Foundation Trust, West Sussex, UK

3General Hospital of Chengdu Military Area, Chengdu, China

4ARNAS Civico-Di Cristina-Benfratelli, Palermo, Italy

5Sao Paulo State University, Botucatu, Brazil


Prognostic Assessment and Management of Liver Cirrhosis

Description

Liver cirrhosis is a major cause of death worldwide. According to the report of Global Burden of Disease Study 2013, the number of all age deaths from liver cirrhosis has increased by 45.6% between 1993 and 2013 (from 838.0 thousand in 1993 to 1221.1 thousand in 2013). Liver cirrhosis is the 13th cause of global years of life lost in 2013. Lots of novel therapies for liver cirrhosis and its complications have been greatly evolved during the past decades. However, liver transplantation remains the sole curative treatment option. Given a dismal prognosis of liver cirrhosis, it is very important for clinicians and patients to understand the potential risk factors for early death and the therapeutic algorithms.

We invite the researchers to contribute original research articles and review articles to explore the prognostic assessment and management of liver cirrhosis. We are particularly interested in high-quality systematic reviews and meta-analyses in this field.

Potential topics include but are not limited to the following:

  • Short- and long-term follow-up outcomes of liver cirrhosis
  • Novel biomarkers or mathematical models for assessing the short- and long-term survival of liver cirrhosis
  • Novel stages of liver cirrhosis
  • Role of nutritional status, portal haemodynamic status, cardiac function, and renal function for the prognostic assessment of liver cirrhosis
  • Impact of therapeutic options on the prognosis of liver cirrhosis, such as direct antiviral drugs, statins, anticoagulants, nonselective beta-blockers in ascites, early use of transjugular intrahepatic portosystemic shunt in high-risk variceal bleeding, endoscopic treatment of variceal bleeding, and so forth
  • Impact of portal vein thrombosis on the prognosis of liver cirrhosis
  • Management of upper gastrointestinal bleeding, ascites, hepatic encephalopathy, hepatic hydrothorax, hypersplenism, hepatic myelopathy, and portal vein thrombosis in liver cirrhosis

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 5326898
  • - Editorial

Prognostic Assessment and Management of Liver Cirrhosis

Xingshun Qi | Ankur Arora | ... | Fernando Gomes Romeiro
  • Special Issue
  • - Volume 2017
  • - Article ID 9281450
  • - Clinical Study

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography

Natasha McDonald | David M. L. Lilburn | ... | Jonathan A. Fallowfield
  • Special Issue
  • - Volume 2017
  • - Article ID 2670658
  • - Research Article

miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway

Tengfei Ma | Xiuqin Cai | ... | Quentin Liu
  • Special Issue
  • - Volume 2017
  • - Article ID 4932759
  • - Research Article

Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns

Maurizio Soresi | Antonino Terranova | ... | Lydia Giannitrapani
  • Special Issue
  • - Volume 2017
  • - Article ID 8523649
  • - Review Article

Advances in the Diagnosis and Treatment of Acute Kidney Injury in Cirrhosis Patients

Lei Lei | Liangping Li | Hu Zhang
  • Special Issue
  • - Volume 2017
  • - Article ID 2067479
  • - Research Article

Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease

Ahmed M. Gharib | Ma Ai Thanda Han | ... | Caryn G. Morse
  • Special Issue
  • - Volume 2017
  • - Article ID 4612769
  • - Research Article

Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation

Xiaopeng Tian | Chunhong Zhao | ... | Xiaolan Zhang
  • Special Issue
  • - Volume 2017
  • - Article ID 1252647
  • - Research Article

Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis

Miao Liu | Lingyao Du | ... | Hong Tang
  • Special Issue
  • - Volume 2017
  • - Article ID 8061091
  • - Research Article

Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment

Geng-lin Zhang | You-ming Chen | ... | Zhi-liang Gao
  • Special Issue
  • - Volume 2017
  • - Article ID 4081525
  • - Review Article

Coronary Computed Tomography Angiography in Combination with Coronary Artery Calcium Scoring for the Preoperative Cardiac Evaluation of Liver Transplant Recipients

Jae Moon Choi | Yu-Gyeong Kong | ... | Young-Kug Kim
BioMed Research International
 Journal metrics
Acceptance rate30%
Submission to final decision66 days
Acceptance to publication36 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.